Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

95% upper bound limit as per FDA for fully replicate crossover BE study [RSABE / ABEL]

posted by dshah – India, 2021-01-05 09:06 (1645 d 20:54 ago) – Posting: # 22174
Views: 3,678

Hi Yogeshla!

❝ Suppose 95% UB result is 0.001, is it acceptable to FDA?

The 95% UB would not be acceptable for 0.001.

Regards,
dshah

Complete thread:

95% upper bound limit as per FDA for fully replicate crossover BE study yogeshla 2021-01-05 07:01 [RSABE / ABEL]
- 95% upper bound limit as per FDA for fully replicate crossover BE studydshah 2021-01-05 08:06
  - 0.001 > 0 Helmut 2021-01-05 11:01
    - 0.001 > 0 yogeshla 2021-01-05 12:33

Admin contact
23,428 posts in 4,929 threads, 1,695 registered users;
67 visitors (0 registered, 67 guests [including 27 identified bots]).
Forum time: 07:00 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere. Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz